Trading Report: The Concert Wealth Management Inc. reached $154,000 position of OraSure Technologies Inc. (OSUR)

The Concert Wealth Management Inc. reached $154,000 position  of OraSure Technologies Inc. (OSUR)

Concert Wealth Management Inc. maintained its position in shares of OraSure Technologies Inc. (NASDAQ:OSUR) during the second quarter, Holdings Channel reports. The firm owned 25,900 shares of the company’s stock at the end of the second quarter. Concert Wealth Management Inc.’s holdings in OraSure Technologies were worth $154,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Renaissance Technologies LLC boosted its stake in OraSure Technologies by 36.5% in the first quarter. Renaissance Technologies LLC now owns 2,693,603 shares of the company’s stock valued at $19,475,000 after buying an additional 720,700 shares during the last quarter. Teachers Advisors Inc. boosted its stake in OraSure Technologies by 4.8% in the first quarter. Teachers Advisors Inc. now owns 1,360,199 shares of the company’s stock valued at $9,834,000 after buying an additional 62,173 shares during the last quarter. Acadian Asset Management LLC boosted its stake in OraSure Technologies by 13.6% in the second quarter. Acadian Asset Management LLC now owns 1,257,995 shares of the company’s stock valued at $7,433,000 after buying an additional 150,526 shares during the last quarter. Hood River Capital Management LLC boosted its stake in OraSure Technologies by 25.7% in the second quarter. Hood River Capital Management LLC now owns 907,759 shares of the company’s stock valued at $5,365,000 after buying an additional 185,722 shares during the last quarter. Finally, American Century Companies Inc. boosted its stake in OraSure Technologies by 58.6% in the second quarter. American Century Companies Inc. now owns 606,623 shares of the company’s stock valued at $3,585,000 after buying an additional 224,212 shares during the last quarter. Institutional investors and hedge funds own 79.30% of the company’s stock.

Shares of OraSure Technologies Inc. (NASDAQ:OSUR) traded down 0.13% during trading on Monday, reaching $7.70. The company’s stock had a trading volume of 431,670 shares. The company has a 50 day moving average of $8.31 and a 200-day moving average of $7.31. The stock has a market cap of $428.12 million, a price-to-earnings ratio of 36.67 and a beta of 1.51. OraSure Technologies Inc. has a 12-month low of $4.75 and a 12-month high of $9.05.

OraSure Technologies (NASDAQ:OSUR) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.05 by $0.02. OraSure Technologies had a return on equity of 7.60% and a net margin of 10.08%. The business earned $31.36 million during the quarter, compared to analyst estimates of $31.15 million. During the same quarter in the previous year, the company posted $0.03 earnings per share. OraSure Technologies’s revenue for the quarter was up 3.2% on a year-over-year basis. Analysts forecast that OraSure Technologies Inc. will post $0.27 EPS for the current year.

OSUR has been the topic of several recent analyst reports. TheStreet cut OraSure Technologies from a “buy” rating to a “hold” rating in a report on Friday, July 1st. Mizuho reissued an “outperform” rating and set a $8.00 price objective on shares of OraSure Technologies in a report on Tuesday, July 5th. BTIG Research cut OraSure Technologies from a “buy” rating to a “neutral” rating and set a $8.00 price objective on the stock. in a report on Monday, September 19th. Canaccord Genuity raised their price objective on OraSure Technologies from $7.00 to $10.00 and gave the company a “buy” rating in a report on Wednesday, August 24th. Finally, Jefferies Group reissued a “buy” rating and set a $10.00 price objective (up from $8.00) on shares of OraSure Technologies in a report on Wednesday, August 31st. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $8.58.

In other news, Director Charles W. Patrick sold 6,575 shares of the company’s stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $7.24, for a total value of $47,603.00. Following the completion of the transaction, the director now owns 77,209 shares of the company’s stock, valued at $558,993.16. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Jack E. Jerrett sold 68,686 shares of the company’s stock in a transaction dated Tuesday, August 30th. The stock was sold at an average price of $8.52, for a total value of $585,204.72. Following the completion of the transaction, the senior vice president now directly owns 86,441 shares of the company’s stock, valued at approximately $736,477.32. The disclosure for this sale can be found here. Company insiders own 7.80% of the company’s stock.

OraSure Technologies Company Profile

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Related posts

Leave a Comment